Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 13Recruiting 5Active not recruiting 3Withdrawn 2Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 13Genitourinary 12Gastrointestinal 12Breast 11Head & Neck 6Tumor-Agnostic 5Other hematologic neoplasm 5Lymphoid 5Thoracic 4Plasma cell 3Other 3Gynecologic 3Other neoplasm 1Myeloid 1Dermatologic 1CNS 1

Conditions

Neoplasms 5

Interventions

pembrolizumab 25Specimen Handling 17Blood Specimen Collection 17Biopsy 16Magnetic Resonance Spectroscopy 15atezolizumab 11Surveys and Questionnaires 11Radiosurgery 9Bevacizumab 9Paclitaxel 8Fluorouracil 8Standard of Care 7Radiotherapy 7Nivolumab 7Irinotecan 7Gemcitabine 7Cisplatin 7Carboplatin 7olaparib 6durvalumab 6Palliative Care 6Oxaliplatin 6Leucovorin 6Cyclophosphamide 6Capecitabine 6alectinib 5abemaciclib 5Trastuzumab 5Interviews as Topic 5Exercise 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Interviews as Topic × Tumor-Agnostic × Clear all
NCT05694650 2026-03-03

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

M.D. Anderson Cancer Center

Recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT05681026 2026-02-27

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

M.D. Anderson Cancer Center

Phase NA Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT07352579 2026-02-12

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Thomas Jefferson University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT00505245 2026-01-21

New Assessment System in Measuring Symptom Distress in Cancer Patients

M.D. Anderson Cancer Center

Recruiting
6,500 enrolled
Tumor-Agnostic

Neoplasms

NCT06278558 2025-03-24

CEMA-P

Centre Hospitalier de Valenciennes

Phase NA Recruiting
289 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡